Lilly shatters its sales record thanks to its anti-obesity drug Mounjaro. The largest pharmaceutical company in the world by market value had a turnover of 34,124 million dollars in 2023.
In patient trials, Lilly's drug caused more weight loss than rivals Ozempic and Novo Nordisk's twin Wegowy. About 70% of American adults are obese or overweight, and many of those who are overweight suffer from a related disease, according to the FDA.